Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103904-74-1

Post Buying Request

103904-74-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103904-74-1 Usage

Molecular structure

The compound has a molecular structure that includes a butyl group (four carbon atoms) and a hydroxylated undecatrienic (11 carbon atoms with three double bonds) chain, which is attached to a benzoic acid group.

Bioactive component

10-HDA is a major bioactive component found in royal jelly, a substance produced by honeybees.

Health benefits

10-HDA has been studied for its potential health benefits, including antioxidant, anti-inflammatory, and antibacterial properties.

Therapeutic effects

The compound has been investigated for its potential therapeutic effects on various health conditions, such as diabetes, cancer, and neurodegenerative diseases.

Nutraceuticals and pharmaceuticals

Due to its promising biological activities, 10-HDA has attracted considerable attention in the field of nutraceuticals and pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 103904-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,9,0 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 103904-74:
(8*1)+(7*0)+(6*3)+(5*9)+(4*0)+(3*4)+(2*7)+(1*4)=101
101 % 10 = 1
So 103904-74-1 is a valid CAS Registry Number.

103904-74-1Downstream Products

103904-74-1Relevant articles and documents

A Heck-Based Strategy to Generate Anacardic Acids and Related Phenolic Lipids for Isoform-Specific Bioactivity Profiling

Weigel, William K.,Dennis, Taylor N.,Kang, Amrik S.,Perry, J. Jefferson P.,Martin, David B. C.

supporting information, p. 6234 - 6238 (2018/10/05)

A synthetic strategy for phenolic lipids such as anacardic acid and ginkgolic acid derivatives using an efficient and selective redox-relay Heck reaction followed by a stereoselective olefination is reported. This approach controls both the alkene position and stereochemistry, allowing the synthesis of natural and unnatural unsaturated lipids as single isomers. By this strategy, the activities of different anacardic acid and ginkgolic acid derivatives have been examined in a matrix metalloproteinase inhibition assay.

Synthesis of polyunsaturated constituents of phenolic lipids

Tyman, John H.P.,Visani

, p. 157 - 174 (2007/10/03)

The diene, (ZZ)-[(8,11)-pentadecadienyl]salicylic acid, (or 2-hydroxy-6-[(ZZ)-pentadeca-8,11-dienyl] acid), has been synthesised by two routes. In the first, the key intermediate methyl or ethyl 2-hydroxy-6-(7-bromoheptyl)benzoate has been converted to methyl or ethyl 2-hydroxy-6-(10-hydroxydec-8-ynyl)benzoate and thence by reaction of the corresponding bromide with 1-pentynylmagnesium bromide to methyl or ethyl 2-hydroxy-6-(pentadeca-8,11-diynyl)benzoate. Selective reduction afforded methyl or ethyl 2-hydroxy-6-[(ZZ)-pentadeca-8,11-dienyl]benzoate. An attempt to employ the Grignard reagent from methyl 2-methoxy-6-(non-8-ynyl)benzoate and reaction with 1-bromohex-2-yne was ineffective because of a side reaction of the former with ethylmagnesium bromide to give a ketone. In the third approach ethyl 2-methoxy-6-methylbenzoate was alkylated with 1-iodotetradeca-7,10-diyne and the product selectively reduced as before to the O-methyl ether ethyl ester. A variety of C14 intermediates has been prepared for the derivation of the 8(E),11(E), 8(E),11(Z) and 8(Z),11(E) stereoisomers by the alkylation procedure. A similar methodology of alkylation can be adopted for obtaining corresponding trienes in which some progress has been made commencing with the synthesis of the 8(Z),11(Z),14 compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103904-74-1